Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study

Heli Eronena Department of Gastroenterology, Kanta-Häme Central Hospital, Hämeenlinna, FinlandCorrespondence[email protected]
View further author information

Sara Kolehmainenb Faculty of Medicine, University of Helsinki, Helsinki, FinlandView further author information

Jukka Koffertc Department of Gastroenterology, Turku University Hospital, Turku, FinlandView further author information

Inka Koskinend Department of Internal Medicine, Central Finland Central Hospital, Jyväskylä, FinlandView further author information

Pia Oksanene Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, and University of Tampere, Tampere, FinlandView further author information

Airi Jussilaf Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, FinlandView further author information

Heini Huhtalag Faculty of Social Sciences, Tampere University, Tampere, Finland

https://orcid.org/0000-0003-1372-430X View further author information

Taina Sipponenh Gastroenterology, Helsinki University Hospital and University of Helsinki, Helsinki, FinlandView further author information

Tuire Ilusf Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, FinlandView further author information

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

John K Triantafillidis, Constantinos G Zografos, Manousos M Konstadoulakis & Apostolos E Papalois. (2024) Combination treatment of inflammatory bowel disease: Present status and future perspectives. World Journal of Gastroenterology 30:15, pages 2068-2080.
Crossref

Magdalena Wlazlo, Monika Meglicka, Anna Wiernicka, Marcin Osiecki, Malgorzata Matuszczyk & Jaroslaw Kierkus. (2024) Combination biologic therapy in pediatric inflammatory bowel disease: Safety and efficacy over a minimum 12‐month follow‐up period. Journal of Pediatric Gastroenterology and Nutrition.
Crossref

Anat Yerushalmy-Feler, Christine Olbjorn, Kaija-Leena Kolho, Marina Aloi, Francesca Musto, Javier Martin-de-Carpi, Ana Lozano-Ruf, Dotan Yogev, Manar Matar, Luca Scarallo, Matteo Bramuzzo, Lissy de Ridder, Ben Kang, Christoph Norden, David C Wilson, Christos Tzivinikos, Dan Turner & Shlomi Cohen. (2024) Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN. Inflammatory Bowel Diseases 30:2, pages 159-166.
Crossref

Cristina Valero-Martínez, Judit Font Urgelles, Meritxell Sallés, Beatriz E. Joven-Ibáñez, Alexia de Juanes, Julio Ramírez, Xavier Juanola, Raquel Almodóvar, Ana Laiz, Mireia Moreno, Manel Pujol, Emma Beltrán, José Antonio Pinto-Tasende, Laura Crespí, Luis Sala-Icardo, Santos Castañeda & Rosario García-Vicuña. (2023) Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology 14.
Crossref

. (2022) Adalimumab/ustekinumab. Reactions Weekly 1937:1, pages 23-23.
Crossref

Nicole M. Garcia, Nathaniel A. Cohen & David T. Rubin. (2022) Treat‐to‐target and sequencing therapies in Crohn's disease. United European Gastroenterology Journal 10:10, pages 1121-1128.
Crossref

Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date